Sara M. Melief

1.2k total citations · 1 hit paper
6 papers, 893 citations indexed

About

Sara M. Melief is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Sara M. Melief has authored 6 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Sara M. Melief's work include Mesenchymal stem cell research (3 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (2 papers). Sara M. Melief is often cited by papers focused on Mesenchymal stem cell research (3 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (2 papers). Sara M. Melief collaborates with scholars based in Netherlands. Sara M. Melief's co-authors include Helene Roelofs, Willem E. Fibbe, Jaap Jan Zwaginga, Martin J. Hoogduijn, Ellen Schrama, Machteld M. Tiemessen, Martijn H. Brugman, Sacha B. Geutskens, Marten Visser and Sjoerd H. van der Burg and has published in prestigious journals such as Stem Cells, Cancer Immunology Immunotherapy and Cancer Immunology Research.

In The Last Decade

Sara M. Melief

6 papers receiving 878 citations

Hit Papers

Adipose Tissue-Derived Multipotent Stromal Cells Have a H... 2013 2026 2017 2021 2013 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara M. Melief Netherlands 6 664 315 253 218 125 6 893
Ramón Menta Spain 14 559 0.8× 268 0.9× 206 0.8× 210 1.0× 114 0.9× 19 773
Shala Yuan Canada 11 696 1.0× 287 0.9× 266 1.1× 256 1.2× 184 1.5× 17 975
Paul Lohan Ireland 16 539 0.8× 314 1.0× 266 1.1× 167 0.8× 147 1.2× 18 968
Anoop Babu Vasandan India 4 555 0.8× 238 0.8× 228 0.9× 171 0.8× 106 0.8× 6 745
Akiko Meguro Japan 8 739 1.1× 292 0.9× 237 0.9× 260 1.2× 154 1.2× 15 970
Aisha Nasef France 7 621 0.9× 278 0.9× 207 0.8× 163 0.7× 113 0.9× 8 793
Oliver Treacy Ireland 16 671 1.0× 380 1.2× 334 1.3× 188 0.9× 191 1.5× 26 1.1k
Pablo Mancheño‐Corvo Spain 14 496 0.7× 223 0.7× 221 0.9× 180 0.8× 120 1.0× 18 727
Lisa O’Flynn Ireland 15 783 1.2× 388 1.2× 344 1.4× 213 1.0× 139 1.1× 21 1.2k
Mats Remberger Sweden 6 722 1.1× 324 1.0× 180 0.7× 179 0.8× 136 1.1× 7 1.0k

Countries citing papers authored by Sara M. Melief

Since Specialization
Citations

This map shows the geographic impact of Sara M. Melief's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara M. Melief with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara M. Melief more than expected).

Fields of papers citing papers by Sara M. Melief

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara M. Melief. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara M. Melief. The network helps show where Sara M. Melief may publish in the future.

Co-authorship network of co-authors of Sara M. Melief

This figure shows the co-authorship network connecting the top 25 collaborators of Sara M. Melief. A scholar is included among the top collaborators of Sara M. Melief based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara M. Melief. Sara M. Melief is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Melief, Sara M., Valeria Visconti, Marten Visser, et al.. (2017). Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature. Cancer Immunology Research. 5(2). 170–179. 24 indexed citations
2.
Melief, Sara M., Marten Visser, Sjoerd H. van der Burg, & Els M.E. Verdegaal. (2017). IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma. Cancer Immunology Immunotherapy. 66(7). 913–926. 16 indexed citations
3.
Melief, Sara M., Jaap Jan Zwaginga, Willem E. Fibbe, & Helene Roelofs. (2013). Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts. Stem Cells Translational Medicine. 2(6). 455–463. 339 indexed citations breakdown →
4.
Melief, Sara M., Sacha B. Geutskens, Willem E. Fibbe, & Helene Roelofs. (2013). Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6. Haematologica. 98(6). 888–895. 131 indexed citations
5.
Melief, Sara M., Ellen Schrama, Martijn H. Brugman, et al.. (2013). Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 31(9). 1980–1991. 327 indexed citations
6.
Maijenburg, Marijke W., Christian Gilissen, Sara M. Melief, et al.. (2011). Nuclear Receptors Nur77 and Nurr1 Modulate Mesenchymal Stromal Cell Migration. Stem Cells and Development. 21(2). 228–238. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026